Latest news
Loading news…
Osmol Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New Haven, Connecticut, United States Founded 2016 1-10 employees For Profit
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 34
- IT spend
- $155K
Company Info
- Founded
- 2016
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 13
- HQ
- New Haven, Connecticut, United States
- Region
- East Coast, New England, Northeastern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 2.1
- Trend (90d)
- 2.8
- Last leadership hire
- Mar 4, 2024
Key People at Osmol Therapeutics
Chief Executive Officer
Chief Medical Officer
Founder and Chief Scientific Advisor
1
professional contacts at Osmol Therapeutics
Contact execs at Osmol Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Osmol Therapeutics
Loading news…
FAQs about Osmol Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.